Clinical trial
NPDT Evaluation in Children With CFTR and (PSC)
NCT00179439 · Beth Israel Deaconess Medical Center, Other · Completed
Key facts
| NCT number | NCT00179439 |
|---|---|
| Title | NPDT Evaluation in Children With CFTR and (PSC) |
| Official title | Nasal Potential Difference Testing: Evaluation of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Function in Children With Primary Sclerosing Cholangitis (PSC) |
| Acronym | NPD |
| Lead sponsor | Beth Israel Deaconess Medical Center, Other |
| Collaborators | Boston Children's Hospital |
| Status | Completed |
| Study type | Observational |
| Conditions | Primary Sclerosing Cholangitis, Inflammatory Bowel Disease |
| Intervention type | Procedure |
| Interventions | nasal potential difference testing |
| Enrollment | 50 |
| Start date | Jan 1, 2004 |
| Primary completion | Jan 1, 2006 |
| Completion | Jan 1, 2006 |
| First posted | Sep 16, 2005 |
| Last update posted | Dec 13, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: